Journal articlePancreatology2024

Phase II study of SOXIRI (S-1/oxaliplatin/irinotecan) chemotherapy in patients with unresectable pancreatic ductal adenocarcinoma.

DOI 10.1016/j.pan.2023.12.008 ↗ OpenAlex, retrieved 5 November 2026

Journal: Pancreatology
Published: 31 December 2023
Citations: 5
Type: Article

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try